113 related articles for article (PubMed ID: 36349938)
1. PPM1G promotes the progression of lung adenocarcinoma by inhibiting p38 activation via dephosphorylation of MEK6.
Chen J; Li J; Sun H; Hu T; Wang Y; Kang G; Cao M; Li X
Carcinogenesis; 2023 May; 44(1):93-104. PubMed ID: 36349938
[TBL] [Abstract][Full Text] [Related]
2. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.
Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and immunological potential of PPM1G in lung adenocarcinoma.
Yin R; Qu L; Wang Z; Tang J; Gu H; Wang X; Yang D; Du P; Dong M
Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37387407
[TBL] [Abstract][Full Text] [Related]
4. Protein phosphatase PPM1G regulates protein translation and cell growth by dephosphorylating 4E binding protein 1 (4E-BP1).
Liu J; Stevens PD; Eshleman NE; Gao T
J Biol Chem; 2013 Aug; 288(32):23225-33. PubMed ID: 23814053
[TBL] [Abstract][Full Text] [Related]
5. KANK3 mediates the p38 MAPK pathway to regulate the proliferation and invasion of lung adenocarcinoma cells.
Dai Z; Xie B; Yang B; Chen X; Hu C; Chen Q
Tissue Cell; 2023 Feb; 80():101974. PubMed ID: 36463587
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol-3 kinase-dependent translational regulation of Id1 involves the PPM1G phosphatase.
Xu K; Wang L; Feng W; Feng Y; Shu HK
Oncogene; 2016 Nov; 35(44):5807-5816. PubMed ID: 27065332
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C-induced activation of a ceramide/protein phosphatase 1 pathway leading to dephosphorylation of p38 MAPK.
Kitatani K; Idkowiak-Baldys J; Bielawski J; Taha TA; Jenkins RW; Senkal CE; Ogretmen B; Obeid LM; Hannun YA
J Biol Chem; 2006 Dec; 281(48):36793-802. PubMed ID: 17030510
[TBL] [Abstract][Full Text] [Related]
8. Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways.
Takekawa M; Maeda T; Saito H
EMBO J; 1998 Aug; 17(16):4744-52. PubMed ID: 9707433
[TBL] [Abstract][Full Text] [Related]
9. WIP1 promotes cancer stem cell properties by inhibiting p38 MAPK in NSCLC.
Deng K; Liu L; Tan X; Zhang Z; Li J; Ou Y; Wang X; Yang S; Xiang R; Sun P
Signal Transduct Target Ther; 2020 Apr; 5(1):36. PubMed ID: 32296033
[TBL] [Abstract][Full Text] [Related]
10. High expression of PPM1G is associated with the progression and poor prognosis of hepatocellular carcinoma.
Xiong DL; Li Q; Wang H; Jin WL; Fan XM; Ma YY
Cancer Biomark; 2022; 34(1):13-22. PubMed ID: 34366322
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells.
Chen L; Mayer JA; Krisko TI; Speers CW; Wang T; Hilsenbeck SG; Brown PH
Cancer Res; 2009 Dec; 69(23):8853-61. PubMed ID: 19920204
[TBL] [Abstract][Full Text] [Related]
12. TRB3 interacts with ERK and JNK and contributes to the proliferation, apoptosis, and migration of lung adenocarcinoma cells.
Cao X; Fang X; Malik WS; He Y; Li X; Xie M; Sun W; Xu Y; Liu X
J Cell Physiol; 2020 Jan; 235(1):538-547. PubMed ID: 31256425
[TBL] [Abstract][Full Text] [Related]
13. E2F1 modulates p38 MAPK phosphorylation via transcriptional regulation of ASK1 and Wip1.
Hershko T; Korotayev K; Polager S; Ginsberg D
J Biol Chem; 2006 Oct; 281(42):31309-16. PubMed ID: 16912047
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade.
Stein B; Brady H; Yang MX; Young DB; Barbosa MS
J Biol Chem; 1996 May; 271(19):11427-33. PubMed ID: 8626699
[TBL] [Abstract][Full Text] [Related]
16. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
[TBL] [Abstract][Full Text] [Related]
17. DLC1 inhibits lung adenocarcinoma cell proliferation, migration and invasion via regulating MAPK signaling pathway.
Niu N; Ma X; Liu H; Zhao J; Lu C; Yang F; Qi W
Exp Lung Res; 2021; 47(4):173-182. PubMed ID: 33678109
[TBL] [Abstract][Full Text] [Related]
18. Activation of p38 has opposing effects on the proliferation and migration of endothelial cells.
McMullen ME; Bryant PW; Glembotski CC; Vincent PA; Pumiglia KM
J Biol Chem; 2005 Jun; 280(22):20995-1003. PubMed ID: 15790570
[TBL] [Abstract][Full Text] [Related]
19. Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.
Pan L; Tan Y; Wang B; Qiu W; Yin Y; Ge H; Zhu H
Cancer Res Treat; 2020 Jul; 52(3):867-885. PubMed ID: 32164050
[TBL] [Abstract][Full Text] [Related]
20. Protease-activated receptor 2 induces migration and promotes Slug-mediated epithelial-mesenchymal transition in lung adenocarcinoma cells.
Tsai CC; Chou YT; Fu HW
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):486-503. PubMed ID: 30321617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
